Skip to main content
  • Saved

made a Post

The Role of Immunotherapy in Non-transplant Eligible Multiple Myeloma

The Role of Immunotherapy in Non-transplant Eligible Multiple Myeloma

Source :

https://doi.org/10.3389/fonc.2020.00676

As the global population is aging and survival in multiple myeloma (MM) is increasing, treating older MM patients, redefined as non-transplant eligible (NTE), is becoming more frequent. Yet, treating these patients remains a real challenge especially because of a marked heterogeneity in the population and an increased susceptibility to treatment toxicity.